리조인 - 테크42

리조인

미 FDA, 세계 최초로 우울증 디지털 치료 앱 승인

2024.04.05

The FDA has approved Rejoyn, a digital treatment for major depressive disorder developed by Otsuka Pharmaceutical and Click Therapeutics, to be used alongside traditional antidepressant medications for individuals 22 and older.